Predictive role of surgical Apgar score for postoperative complications and survival in patients receiving esophagectomy: a meta-analysis

手术 Apgar 评分对食管切除术后并发症和患者生存率的预测作用:一项荟萃分析

阅读:4

Abstract

PURPOSE: The association between surgical Apgar score (SAS) and clinical outcomes among patients undergoing esophagectomy remains uncertain now. This study aimed to further identify the predictive role of SAS for postoperative complications and survival in patients receiving esophagectomy. METHOD: PubMed, EMbase and Web of Science databases were searched up to March 27, 2025. Primary endpoints included the postoperative overall complication (OC) and overall survival (OS) and secondary endpoints consists of specific complications and disease-free survival (DFS). Odds ratios (ORs) and hazard ratios (HRs) with 95% confidence intervals (CIs) were combined to assess the predictive value of SAS for complications and survival, respectively. RESULTS: Ten studies with 2453 patients were included. Pooled results demonstrated that SAS was significantly related to the risk of overall complications (OR = 0.43, 95% CI: 0.33–0.57, P<0.001), but not associated with OS (HR = 0.84, P = 0.246). Furthermore, a low SAS predicted increased risk of anastomotic leakage (OR = 0.44, P = 0.004), chylothorax (OR = 0.33, P = 0.020), infection (OR = 0.43, P<0.001), 30-day mortality (OR = 0.40, P = 0.011), pneumonia (OR = 0.61, P = 0.037), reintubation (OR = 0.29, P = 0.003), respiratory complication (OR = 0.49, P = 0.014), gastrointestinal complication (OR = 0.57, P = 0.035), length of stay (OR = 0.60, P = 0.038), pulmonary complication (OR = 0.46, P = 0.003). However, SAS was not associated with the risk of other complications such as the cardiac complication (P = 0.215) and sepsis (P = 0.087) and DFS (P = 0.341) in esophageal cancer patients. CONCLUSION: SAS may serve as novel prognostic indicator for postoperative complications in patients receiving esophagectomy and low SAS predicts increased risk for complications. However, more studies are needed to further verify above findings. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13019-026-03906-3.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。